113 related articles for article (PubMed ID: 8597429)
1. Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress?
Song C; Earley B; Leonard BE
Ann N Y Acad Sci; 1995 Dec; 771():55-72. PubMed ID: 8597429
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic pretreatment with the sigma ligand JO 1784 on CRF-induced changes in behaviour, neurotransmitter and immunological function in the rat.
Song C; Earley B; Leonard BE
Neuropsychobiology; 1997; 35(4):200-4. PubMed ID: 9246222
[TBL] [Abstract][Full Text] [Related]
3. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression.
Song C; Earley B; Leonard BE
Brain Behav Immun; 1996 Mar; 10(1):1-16. PubMed ID: 8735565
[TBL] [Abstract][Full Text] [Related]
4. Corticotropin-releasing factor produces fear-enhancing and behavioral activating effects following infusion into the locus coeruleus.
Butler PD; Weiss JM; Stout JC; Nemeroff CB
J Neurosci; 1990 Jan; 10(1):176-83. PubMed ID: 2299391
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 beta mediates stress-induced immunosuppression via corticotropin-releasing factor.
Saperstein A; Brand H; Audhya T; Nabriski D; Hutchinson B; Rosenzweig S; Hollander CS
Endocrinology; 1992 Jan; 130(1):152-8. PubMed ID: 1309324
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety.
Takahashi LK; Ho SP; Livanov V; Graciani N; Arneric SP
Brain Res; 2001 Jun; 902(2):135-42. PubMed ID: 11384606
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-2-induced changes in behavioural, neurotransmitter, and immunological parameters in the olfactory bulbectomized rat.
Song C; Leonard BE
Neuroimmunomodulation; 1995; 2(5):263-73. PubMed ID: 8739199
[TBL] [Abstract][Full Text] [Related]
8. Effects of morphine on hypothalamic corticotropin-releasing factor (CRF), norepinephrine and dopamine in non-stressed and stressed rats.
Suemaru S; Hashimoto K; Ota Z
Acta Med Okayama; 1985 Dec; 39(6):463-70. PubMed ID: 3004111
[TBL] [Abstract][Full Text] [Related]
9. Corticotropin-releasing factor (CRF), but not corticosterone, increases basolateral amygdala CRF-binding protein.
Herringa RJ; Mackenrodt DB; Barlow JD; Roseboom PH; Nanda SA; Kalin NH
Brain Res; 2006 Apr; 1083(1):21-8. PubMed ID: 16545343
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of central CRF systems mediates stress-induced changes in noradrenaline and serotonin turnover in rat brain regions.
Li J; Takeda H; Tsuji M; Liu L; Matsumiya T
Methods Find Exp Clin Pharmacol; 1998 Jun; 20(5):409-17. PubMed ID: 9701779
[TBL] [Abstract][Full Text] [Related]
11. Behavioral responses to stress are intact in CRF-deficient mice.
Dunn AJ; Swiergiel AH
Brain Res; 1999 Oct; 845(1):14-20. PubMed ID: 10529439
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.
Rodríguez de Fonseca F; Rubio P; Menzaghi F; Merlo-Pich E; Rivier J; Koob GF; Navarro M
J Pharmacol Exp Ther; 1996 Jan; 276(1):56-64. PubMed ID: 8558457
[TBL] [Abstract][Full Text] [Related]
13. The role of limbic and hypothalamic corticotropin-releasing factor in behavioral responses to stress.
Menzaghi F; Heinrichs SC; Pich EM; Weiss F; Koob GF
Ann N Y Acad Sci; 1993 Oct; 697():142-54. PubMed ID: 8257007
[TBL] [Abstract][Full Text] [Related]
14. The effects of intracerebroventricularly injected corticotropin-releasing factor (CRF) on the central nervous system: behavioural and biochemical studies.
Matsuzaki I; Takamatsu Y; Moroji T
Neuropeptides; 1989 Apr; 13(3):147-55. PubMed ID: 2785246
[TBL] [Abstract][Full Text] [Related]
15. Rapid changes in monoamine levels following administration of corticotropin-releasing factor or corticosterone are localized in the dorsomedial hypothalamus.
Lowry CA; Burke KA; Renner KJ; Moore FL; Orchinik M
Horm Behav; 2001 May; 39(3):195-205. PubMed ID: 11300710
[TBL] [Abstract][Full Text] [Related]
16. Centrally administered norepinephrine modifies the behavior induced by corticotropin-releasing factor in neonatal chicks.
Zhang R; Tachibana T; Takagi T; Koutoku T; Denbow DM; Furuse M
J Neurosci Res; 2003 Nov; 74(4):630-6. PubMed ID: 14598308
[TBL] [Abstract][Full Text] [Related]
17. Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats.
Biró E; Sarnyai Z; Penke B; Szabó G; Telegdy G
Neuroendocrinology; 1993; 57(2):340-5. PubMed ID: 8510808
[TBL] [Abstract][Full Text] [Related]
18. Endocrine and behavioural responses to acute central CRF challenge are antagonized in the periphery and CNS, respectively, in C57BL/6 mice.
Pryce CR; Siegl S; Mayer R; Rahmanzadeh G; McAllister KH
Neuropharmacology; 2011; 60(2-3):318-27. PubMed ID: 20868699
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic and acute stressors and CRF on depression-like behavior in mice.
Swiergiel AH; Leskov IL; Dunn AJ
Behav Brain Res; 2008 Jan; 186(1):32-40. PubMed ID: 17716752
[TBL] [Abstract][Full Text] [Related]
20. Neurobiology of stress and cocaine addiction. Studies on corticotropin-releasing factor in rats, monkeys, and humans.
Sarnyai Z
Ann N Y Acad Sci; 1998 Jun; 851():371-87. PubMed ID: 9668628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
